PHVS

NASD Pharvaris N.V.
Oct 6, 2026 · 12:47 AM ET EOD Market Closed

$30.49 ↑ +0.00 (+0.00%) Trading Up from the previous close of $30.49, $0.98 below the day’s high of $31.47

YTD change
+9.87%
vs 20-day SMA
-13.14%
vs 200-day SMA
+0.13%

Price ranges

Previous day
$30.69 $31.55
open $31.21 close $31.19
-$0.02 (-0.06%)
Today
$30.15 $31.47
open $31.19 now $30.49
-$0.70 (-2.24%)
Past week
$30.69 $32.46
from $32.02 now $30.49
-$1.53 (-4.78%)
Past month
$30.69 $43.25
from $35.66 now $30.49
-$5.17 (-14.50%)
This year
$23.62 $43.25
from $27.75 now $30.49
+$2.74 (+9.87%)

Price & Performance

+2.12 (+7.47%) / 6M

$25.65$30.38$35.11$39.84Apr 6Jul 7Oct 5

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 29.5% away from all-time highs of $43.25
  • PHVS is up 10% since the beginning of the year
  • PHVS is up 30% over the past 12 months
  • PHVS is down 14% over the past 1 month
  • 3% of all PHVS investors are betting against PHVS

PHVS reads poor: price sits above one of the two key moving averages, the 12-month move is +31.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.80794
Earnings momentum +0.6% Quarterly EPS growth
Quarterly change +0.6%

Valuation

P/E ratio N/A
Enterprise value $1.8B
Beta -0.01

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$363.9M
Debt$770.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $2.1B

Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,143.12 +0.02%
JNJ Johnson & Johnson $252.93 -1.21%
ABBV AbbVie, Inc. $265.76 +1.12%
MRK Merck & Co., Inc. $139.54 -3.30%
RHHVF Roche Holding Ltd $427.89 -0.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.